- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.08. | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 | - | HKEx | ||
| 18.08. | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | 1 | HKEx | ||
| 05.08. | Venus Medtech (Hangzhou) Inc.: Court Sides with Cardiovalve in Edwards patent spat | 177 | PR Newswire | HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary... ► Artikel lesen | |
| 27.06. | VENUS MEDTECH-B (02500): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 27.06. | VENUS MEDTECH-B (02500): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 27.06. | VENUS MEDTECH-B (02500): (1) POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING; AND (2) ELECTION OF CHAIRMAN OF THE BOARD AND MEMBERS OF COMMITTEES OF THE ... | 1 | HKEx | ||
| VENUS MEDTECH Aktie jetzt für 0€ handeln | |||||
| 05.06. | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2024 ANNUAL GENERAL MEETING | - | HKEx | ||
| 05.06. | VENUS MEDTECH-B (02500): NOTICE OF 2024 ANNUAL GENERAL MEETING | 2 | HKEx | ||
| 05.06. | VENUS MEDTECH-B (02500): (1) 2024 ANNUAL REPORT (2) WORK REPORT OF THE BOARD FOR 2024 (3) WORK REPORT OF THE SUPERVISORY COMMITTEE FOR 2024 (4) PROFIT ... | - | HKEx | ||
| 30.05. | VENUS MEDTECH-B (02500): (1) PROPOSED RE-ELECTION AND APPOINTMENT OF DIRECTORS FOR THE THIRD SESSION OF THE BOARD; AND (2) PROPOSED RE-ELECTION AND APPOINTMENT ... | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND REPLY FORM | 2 | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND REPLY FORM | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2024 ANNUAL REPORT | 1 | HKEx | ||
| 22.04. | Venus Medtech (Hangzhou) Inc.: Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations | 430 | PR Newswire | HONG KONG, April 22, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart... ► Artikel lesen | |
| 28.03. | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 | - | HKEx | ||
| 20.03. | VENUS MEDTECH-B (02500): PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE | 2 | HKEx |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 16,320 | 0,00 % | Alignment Healthcare, Inc. - 8-K, Current Report | ||
| KINDLY MD | 1,240 | 0,00 % | KindlyMD, Inc: KindlyMD Approved for Options Trading on Nasdaq | SALT LAKE CITY, UT / ACCESS Newswire / September 10, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury vehicle via... ► Artikel lesen | |
| NANOVIBRONIX | 10,700 | 0,00 % | NanoVibronix files to sell 1.35M shares of common stock for holders | ||
| BRIGHTSPRING HEALTH SERVICES | 27,180 | 0,00 % | BrightSpring Health: UBS bestätigt Kaufempfehlung angesichts starker Wachstumsaussichten | ||
| FRESENIUS | 47,000 | +0,30 % | +40 Prozent seit Jahresbeginn: Fresenius kehrt mit Milliarden-Anleihe zurück - Analysten empfehlen zum Kauf! | © Foto: Arne Dedert/dpaFresenius stärkt mit einer Milliarden-Anleihe seine Bilanz und Analysten sehen trotz Rallye weiteres Kurspotenzial für die Aktie.Der Gesundheitskonzern Fresenius ist mit einer... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,260 | +0,48 % | FMC, Hugo Boss, K+S, Redcare Pharmacy, Renk, ThyssenKrupp - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BETA BIONICS | 25,310 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,900 | +0,19 % | Siemens Healthineers - kann ein möglicher Verkauf einer Problemsparte die Aktie beflügeln? | ||
| OPTIMIZERX | 17,330 | 0,00 % | OptimizeRx Corporation: OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising | Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept.... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,340 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 37,980 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 296,05 | +0,08 % | Neues Futter für Bullen: UnitedHealth überrascht mit Gewinnprognose für 2025 - Aktie steigt! | © Foto: SOPA Images - Sipa USAUnitedHealth bekräftigt trotz steigender Kosten seinen Jahresausblick, die Aktie reagiert mit einem Kurssprung von 1,5 Prozent.Die Aktie von UnitedHealth Group legte am... ► Artikel lesen | |
| OMADA HEALTH | 22,140 | 0,00 % | Omada Health Announces Pricing of Initial Public Offering | SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual between-visit healthcare provider, today announced the pricing of its initial public offering of 7,900,000 shares of its common stock, at a... ► Artikel lesen | |
| NUTEX HEALTH | 95,66 | 0,00 % | Nutex Health, Inc.: Nutex Health Provides Financial Reporting Update | HOUSTON, Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system... ► Artikel lesen | |
| MIMEDX | 6,970 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results | Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06... ► Artikel lesen |
Das Unternehmen VENUS MEDTECH HANGZHOU INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS MEDTECH HANGZHOU INC finden Sie auf Wallstreet Online.